The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence. Luis M, Boers M, Saag K, Buttgereit F, et al. Curr Opin Rheumatol 2022;34:179-186.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Luis M, Boers M, Saag K, Buttgereit F, et al. The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence. Curr Opin Rheumatol 2022;34:179-186.
PMID: 35238807